Rockefeller Capital Management’s Sanara MedTech SMTI Stock Holding History

Rockefeller Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Hold	14,393	–	–	﹤0.01%	2289
2026 Q1	$247K	Buy	14,393 +1,599	+12%	+$32.9K	﹤0.01%	2360
2025 Q4	$299K	Buy	+12,794	New	+$330K	﹤0.01%	2161
2023 Q3	–	Sell	-5,500	Closed	-$221K	–	1788
2023 Q2	$221K	Hold	5,500	–	–	﹤0.01%	1615
2023 Q1	$226K	Hold	5,500	–	–	﹤0.01%	1749
2022 Q4	$250K	Hold	5,500	–	–	﹤0.01%	1563
2022 Q3	$163K	Hold	5,500	–	–	﹤0.01%	1740
2022 Q2	$114K	Hold	5,500	–	–	﹤0.01%	1871
2022 Q1	$156K	Buy	5,500 +1,000	+22%	+$25.4K	﹤0.01%	1801
2021 Q4	$132K	Hold	4,500	–	–	﹤0.01%	1817
2021 Q3	$154K	Buy	4,500 +1,500	+50%	+$53.8K	﹤0.01%	1671
2021 Q2	$110K	Buy	3,000 +2,000	+200%	+$58.5K	﹤0.01%	1761
2021 Q1	$31K	Buy	+1,000	New	+$34.7K	﹤0.01%	2098

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Rockefeller Capital Management's SMTI Position: Q2 2026 in Review

Rockefeller Capital Management held its Sanara MedTech (SMTI) position steady in Q2 2026 at 14,393 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Rockefeller Capital Management first reported a position in SMTI in Q1 2021 and has held it in 13 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Rockefeller Capital Management held 14,393 shares of Sanara MedTech worth $340K as of Q2 2026.
Rockefeller Capital Management left its Sanara MedTech share count unchanged in Q2 2026.
Sanara MedTech made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2289 holding.
Rockefeller Capital Management first reported a position in Sanara MedTech in Q1 2021 and has held it in 13 quarters since.
74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.